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Introduction: The management of inferior parathyroid glands during central neck dissection (CND) for
papillary thyroid carcinoma (PTC) remains controversial. Most surgeons preserve inferior parathyroid
glands in situ. Autotransplantation is not routinely performed unless devascularization or inadvertent
parathyroidectomy occurs. This retrospective study aimed to compare the incidence of postoperative
hypoparathyroidism and central neck lymph node (CNLN) recurrence in patients with PTC who under-
went inferior parathyroid glands autotransplantation vs preservation in situ. Methods: This is a retro-
spective study which was conducted in a tertiary referral hospital. A total of 477 patients with PTC (pN1)
who underwent total thyroidectomy (TT) and bilateral CND with/without lateral neck dissection were
included. Patients' demographical characteristics, tumor stage, incidence of hypoparathyroidism, CNLN
recurrence and the number of resected CNLN were analyzed. Results: Three hundred and twenty-one
patients underwent inferior parathyroid glands autotransplantation (autotransplantation group). Infe-
rior parathyroid glands were preserved in situ among 156 patients (preservation group). Permanent
hypoparathyroidism rate was 0.9% (3/321) versus 3.8% (6/156) respectively (p ¼ 0.028). Mean numbers of
resected CNLN were 15 ± 3 (6e23) (autotransplantation group) versus 11 ± 3 (7e21) (preservation
group) (p < 0.001). CNLN recurrence rate was 0.3% (1/321) versus 3.8% (6/156) respectively (p ¼ 0.003).
Conclusion: Inferior parathyroid glands autotransplantation during CND of PTC (pN1) might reduce
permanent hypoparathyroidism and CNLN recurrence. Further study enrolling more patients with long-
term follow-up is needed to support this conclusion.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.83rd Annual Meeting of the
.
hengdu, Sichuan 610041, PR.
by Elsevier Ltd. All rights reserved1. Introduction
Papillary thyroid carcinoma (PTC) is the most common endo-
crine malignancy worldwide and its incidence has increased
dramatically over the past decades [1e4]. Although the 10-year
survival is over 90%, PTC frequently recurs and metastasizes to the
regional lymph nodes [5e7]. A central neck dissection (CND) is
strongly recommended for PTC patients who have positive central
neck lymph nodes (CNLN) [8,9]..
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situ during CND unless devascularization occurred or there was
tumor involvement. For the inferior parathyroid glands however,
the management remains controversial. Most surgeons prefer to
preserve the inferior parathyroid glands in situ. Elective excision
with autotransplantation is not performed unless devascularization
occurs [10,11]. While Kikumori et al. demonstrated in their study
that autotransplanted parathyroid gland could survive and function
[12,13], it is difﬁcult to estimate the functional status of the para-
thyroid glands preserved in situ. Furthermore, it is unclear whether
inferior parathyroid glands preservation could potentially jeopar-
dize the extent of CND.
In this study, we sought to compare the incidence of post-
operative hypoparathyroidism and CNLN recurrence in PTC pa-
tients who underwent inferior parathyroid glands
autotransplantation vs preservation in situ.
2. Materials and methods
2.1. Study population
Seven hundred and thirteen patients with PTC (pN1) underwent
total thyroidectomy (TT) and bilateral CND with/without lateral
neck dissection by the same surgeon at West China Hospital of
Sichuan University from February 2007 to February 2012. Patients
were enrolled in the study if they (1) were evaluated by preoper-
ative imaging studies including neck ultrasonography and
computed tomography (CT); (2) had biopsy proven PTC; (3) un-
derwent total thyroidectomy and bilateral CND as initial treatment;
(4) staged as pathological N1.
From the initial cohort of 713 patients, 27 had no records of
parathyroid glands, 49 had one or two superior parathyroid glands
autotransplantation, 14 had no inferior parathyroid glands found
intraoperatively (9 had parathyroid glands identiﬁed in the ﬁnal
pathology), 146 had one inferior parathyroid gland auto-
transplantation and the other one preservation in situ (63 had
parathyroid glands at the thymus tongue which could be preserved
in situ viably). These patients were excluded.
As a result, 477 patients with both their superior parathyroid
glands preserved in situ were included in the ﬁnal analysis, who
had either both of their inferior parathyroid glands preserved in
situ or they were both autotransplanted and both their superior
parathyroid glands preserved in situ.
2.2. Preoperative imaging studies
All patients underwent ultrasonography and contrast-enhanced
CT scan preoperatively. Ultrasound was performed by one of the 2
doctors who specialize in head and neck ultrasonography, which
included both thyroid and neck lymph nodes (IeVI levels). CT scan
was performed to identify suspected lateral neck lymph nodes in-
volvements and lung metastasis.
2.3. Fine needle aspiration (FNA)
All patients underwent FNA of thyroid nodule and had cyto-
logical diagnosis of PTC or suspicious for PTC preoperatively. For
suspicious cases, intraoperative frozen section was performed.
2.4. Surgical conduct for PTC at West China Hospital
Total thyroidectomy (TT) was performed for conﬁrmed PTC
larger than 1 cm, or bilateral foci, or extrathyroidal extension, or
lymph node metastasis, or distant metastasis.A complete CND was performed ﬁrst on the side of PTC. If more
than 1 lymph node (ipsilateral paratracheal, pretracheal and prel-
aryngeal nodes) were found to be positive in the central contents by
frozen section, a contralateral CND would follow. We did bilateral
CND for bilateral foci or isthmus foci. Based on preoperative im-
aging study, patients with suspected lateral neck lymph nodes
metastases will undergo concurrent unilateral or bilateral modiﬁed
lateral neck dissection.
All surgeries were performed by a single experienced surgeon
with high-volume thyroid surgeries. TT and bilateral CND was
performed for all patients in this study. Compartment of the central
neck is bounded superiorly by the thyroid cartilage, inferiorly by
the innominate artery, medially by the trachea, and laterally by the
carotid artery (level VIeVII).
Harmonic Scalpels and bipolar coagulation forceps were used. A
meticulous capsular dissection technique was applied for. An “en-
bloc” resectionwas used for all cases. The recurrent laryngeal nerve
was identiﬁed and preserved in the aid of the intraoperative nerve
monitoring.
2.5. Parathyroid glands management
When TT and CND was performed, we routinely identiﬁed the
superior parathyroid gland and preserved it in situ. For inferior
parathyroid glands, they were preserved in situ (preservation
group) if vascular pedicle was kept intact by the surgeon's verdict.
Autotransplantation was performed when devascularization or
inadvertent parathyroidectomies occurred (autotransplantation
group). A small piece of the suspected inferior parathyroid gland
was sent for frozen section, and the rest was placed in iced saline.
After pathological conﬁrmation, the parathyroid tissue would be
minced into 1 mm pieces and transplanted into sternocleidomas-
toid. The same procedure is performed for the contralateral CND.
We reestimated the viability of preserved parathyroid glands at the
end of the surgery. Autotransplantation was then performed if the
surgeon predicted a low probability of gland survival.
2.6. Postoperative complications
All patients underwent total serum calcium and intact para-
thyroid hormone (iPTH) level measurements the ﬁrst postoperative
day. Hypoparathyroidism was deﬁned as a serum iPTH level (the
ﬁrst postoperative day) lower than 1.60 pmol/L (normal range
1.60e6.90 pmol/L). Transient hypoparathyroidism was deﬁned as
serum calcium and iPTH level normalization within 6 months after
surgery. Permanent hypoparathyroidism was deﬁned as a serum
iPTH level lower than 1.60 pmol/L, associated with low serum
calcium level and requiring oral calcium supplementation for more
than 6 months after surgery. Oral calcium supplementation was
administered for all patients with hypoparathyroidism.
If hoarseness occurred postoperatively, a laryngoscopywould be
performed to conﬁrm vocal cord palsy.
2.7. Radioiodine treatment and follow-up strategy
Patients were referred to endocrinologist for further treatment
after surgery. Radioactive iodine remnant ablation was performed
using 100e200 mCi 131I for patients who indicated according to the
American Thyroid Association guidelines. All patients received
suppressive doses of levothyroxine immediately after surgery ac-
cording to risk stratiﬁcation.
Patients received regular follow-up every 3e6 months. For all
patients, the ﬁrst diagnostic whole body nuclear scanwith 131I (due
to unavailability of 123I) and measurement of thyroglobulin levels
during thyroid hormone withdrawal were carried out at 6e8
Table 2
Pathologic stage and lymph node status.
No. of patients (%) p value
Autotransplantation
group
Preservation
group
Total patients 321 156 e
pTN status
pT1-2 165 (51.4) 80 (51.3) 0.98b
pT3-4 156 (48.6) 76 (48.7) 0.98b
pN1a 180 (56.1) 91 (58.3) 91 (58.3)
pN1b 141 (43.9) 65 (41.7) 65 (41.7)
Resected CNLNa
Mean ± SD 15 ± 3 11 ± 3 <0.001c
Range (6e23) (7e21)
Metastatic CNLN
Mean ± SD 10 ± 3 7 ± 3 <0.001c
Range (1e20) (1e19)
CNLN Metastases
Ipsilateral 190 (59.2) 94 (60.3) 0.824b
Bilateral 131 (40.8) 62 (39.7) 0.824b
Recurrence
CNLN 1 (0.3) 6 (3.8) 0.003b
LNLNd 12 (3.7) 7 (4.5) 0.695b
a CNLN central neck lymph node.
b Chi-square test.
c t-test.
d LNLN lateral neck lymph node.
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thyroglobulin, antithyroglobulin antibody and thyrotropin were
obtained yearly thereafter. When the stimulated serum thyro-
globulin level was >5 ug/L or in cases wherein recurrence was
clinically suspicious, neck ultrasonography and/or positron emis-
sion tomography/computed tomography (PET/CT) was performed
to diagnose and localize the recurrence. When suspicious lesion
was identiﬁed, FNA biopsy was performed and if conﬁrmed, exci-
sion of the recurrence would be undertaken.
2.8. Statistical analysis
SPSS 20.0 (SPSS Statistics 20.0) was used for data analysis.
Continuous variables are represented as mean ± standard devia-
tion. T-test was used to compare continuous variables, while Chi-
square test or Fisher's exact test was used for categorical vari-
ables. Statistical signiﬁcance was deﬁned as a p value of <0.05.
3. Results
The demographic information is listed in Table 1. Therewere 321
patients in the autotransplantation group vs 156 patients in the
preservation group. There was no signiﬁcant difference between
the two groups.
3.1. Histopathological examinations
All patients had CNLN metastases and 206 (206/477, 43.2%)
patients had both CNLN and lateral neck lymph node (LNLN) me-
tastases. There were 190 patients (190/321, 59.2%) with ipsilateral
and 131 patients (131/321, 40.8%) with bilateral CNLNmetastases in
autotransplantation group vs 94 patients (94/156, 60.3%) with
ipsilateral and 62 patients (62/156, 39.7%) with bilateral CNLN
metastases in preservation group. Of these, 165 patients (165/321,
51.4%) were staged pT1-2N1 and 156 patients (156/321, 48.6%) were
staged pT3-4N1 in autotransplantation group vs 80 patients (80/
156, 51.3%) were staged pT1-2N1 and 76 patients (76/156, 48.7%)
were staged pT3-4N1 in preservation group. There were 141 (141/
321, 43.9%) patients with both CNLN and LNLN metastases (pN1b)
in autotransplantation group vs 65 (65/156, 41.7%) patients in
preservation group. There was no signiﬁcant difference between
the 2 groups with respect to the pathological stage (pT1-2, pT3-4,
pN1a, pN1b), and CNLN metastases (ipsilateral, bilateral)
(Table 2). Mean number of resected CNLN was 15 ± 3 in auto-
transplantation group vs 11 ± 3 in preservation group. Mean
number of metastatic CNLN was 10 ± 3 in autotransplantation
group vs 7 ± 3 in preservation group. Those were signiﬁcantly
greater in autotransplantation group than in preservation group
(p < 0.001) (Table 2).Table 1
Patients' demographics.
No. of patients (%) p value
Autotransplantation
group
Preservation group
Total patients 321 156 e
Age (yrs)
Mean ± SD 46.41 ± 8.36 44.09 ± 8.34 0.173a
Range (14e72) (15e69)
Gender (female:
male ratio)
5.29 5.00 0.828b
Female 270 (84.8) 130 (83.5) e
Male 51 (15.2) 26 (16.5) e
a t-test.
b Chi-square test.3.2. Surgical complications
Surgical complications of CND are listed in Table 3. The inci-
dence of transient hypoparathyroidism was similar in 2 groups.
With regard to permanent hypoparathyroidism, the incidence was
signiﬁcantly lower in the autotransplantation group than in the
preservation group. Therewas no unintentional recurrent laryngeal
nerve injury in either group. In this study, 4 and 8 patients had
voice change post surgery in preservation and autotransplantation
group respectively. They all had an ipsilateral recurrent laryngeal
nerve of tumor invasion, so a nerve segment resection with/
without reconstructionwas performed for these patients. For them,
a laryngoscopy would not be performed even though they had
voice change.
3.3. Follow-up time, CNLN recurrence and radioiodine treatment
The mean follow-up time was similar in 2 groups (52 ± 11
months in autotransplantation group and 51 ± 9 months in pres-
ervation group) (Table 3). During the follow-up period, 1 in 321
patients experienced CNLN recurrence in the autotransplantation
group, representing a recurrence rate of 0.3%. By contrast, CNLN
recurrence rate was 3.8% (6/156) in the preservation group
(p ¼ 0.003). In the autotransplantation group, the only recurrenceTable 3
Follow-up time, postoperative complications and radioiodine treatment.
No. of patients (%) p value
Autotransplantation
group
Preservation
group
Total patients 321 156 e
Radioiodine treatment 315 (98.1) 151 (96.8) 0.362b
Transient hypoparathyroidism 85 (26.5) 39 (25.0) 0.73b
Permanent hypoparathyroidism 3 (0.9) 6 (3.8) 0.028b
Follow-up time (months)
Mean ± SD 52 ± 11 51 ± 9 0.225a
Range (23e80) (24e81)
a t-test.
b Chi-square test.
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recurred in 1 case and level VI (in the vicinity of preserved inferior
parathyroid) lymph nodes recurred in 5 cases. There was no
recurrence in the thyroid bed in either group. LNLN recurrence was
similar in the 2 groups, 3.7% (12/321) versus 4.5% (7/156). Among
the 6 patients with CNLN recurrence in preservation group, 3 were
staged pT3N1a, 2 were pT2N1b, 1 was pT4N1a. The time interval
post surgery when recurrence occurred ranged from 18 to 34
months. The only patients with CNLN recurrence in auto-
transplantation group, which was found in 24months post surgery,
was staged pT2N1a. All of the patients with CNLN recurrence un-
derwent radioiodine therapy.
A similar proportion of patients received radioiodine treatment
in 2 groups, 315/321 (98.1%) versus 151/156 (96.8%) (p ¼ 0.362).4. Discussion
Regional lymph node metastases develop in 20e90% of patients
with PTC [14e17]. There is a consensus on performing CND for
patients with CNLN metastases [8,18]. CND may convert some pa-
tients from clinical N0 to pathologic N1a, upstaging patients over
age 45 from American Joint Committee on Cancer (AJCC) stage I to
III [19]. The most common adverse event associated with CND is
hypoparathyroidism. Studies have showed that the incidence of
transient hypoparathyroidism and permanent hypoparathyroidism
were up to 20e25% and 5e7%, respectively, when total thyroidec-
tomy with or without CND was performed [20e24].
Most surgeons manage parathyroid glands based on their
intraoperative assessment during CND, by either preservation in
situ or autotransplantation. In our experience, the superior para-
thyroid glands are easier to be identiﬁed and preserved in situ
during CND because the anatomic location and the vessels of su-
perior parathyroid glands are relatively constant compared with
inferior parathyroid glands. For the inferior parathyroid glands
however, the management remains controversial. Most surgeons
prefer to preserve the inferior parathyroid glands in situ. Elective
excision with autotransplantation is not performed unless devas-
cularization occurs [10,11]. Further more, it is unclear whether
inferior parathyroid glands preservation could potentially jeopar-
dize the extent of CND because the inferior parathyroid glands and
enlarged lymph nodes usually mixed together. So we sought to
compare the incidence of postoperative hypoparathyroidism and
CNLN recurrence in PTC patients who underwent inferior para-
thyroid glands autotransplantation versus preservation in situ. To
obtain the aim of the study, the typical patients who had either
both of their inferior parathyroid glands preserved in situ or they
were both autotransplanted and both their superior parathyroid
glands preserved in situ were included.
In the results, the patients' demographic, pathologic stage and
postoperative radioiodine were similar in 2 groups (Table 1,
Table 2). Mean number of resected CNLN and positive CNLN was
greater in autotransplantation group than in preservation group
statistically (Table 2). Increased yield of CNLN might mean better
dissection of CNLN for PTC with similar primary tumor and lymph
node status. LNLN recurrence rate was similar in 2 groups while
CNLN recurrence rate signiﬁcantly reduced in autotransplantation
group within a similar follow-up period. And among the 6 recur-
rence cases in the preservation group, 5 were in level VI (in the
vicinity of preserved inferior parathyroid). The lower CNLN recur-
rence rate in the autotransplantation groupmight be due to a better
CND without the interference of inferior parathyroid glands.
Radioiodine treatment might contribute to reduce local lymph
nodes recurrence [25,26]. The proportion of radioiodine treatment
was similar in the 2 groups. The period of follow up is not longenough for PTC, which is a slowly progressive cancer, may be it is
the reason that the incidence of recurrence in this study was low.
The incidence of transient hypoparathyroidism was similar in 2
groups. With regard to permanent hypoparathyroidism, the inci-
dence was signiﬁcantly lower in the autotransplantation group
than in the preservation group. It is well-known that autotrans-
plants may take several weeks to several months to function. If one
group is having their parathyroid glands removed and reimplanted,
one would have to anticipate a higher rate of transient hypopara-
thyroidism. The fact is that the autotransplantation patients actu-
ally did the same when considering transient hypoparathyroidism
and better when considering permanent hypoparathyroidism,
which means that is unreliable to judge the function of preserved
parathyroid glands by gross eye. Even if the surgeons are conﬁdent
that the vascular supply of parathyroid glands are preserved, there
is no effective way of estimation the function of preserved para-
thyroid glands. Intraoperative PTH assay may be predictive of
postoperative hypoparathyroidism however, normal PTH levels do
not exclude permanent hypoparathyroidism after thyroidectomy
[27,28]. A study by Kikumori et al. demonstrated that the para-
thyroid gland could be grafted successfully and function [12]. These
ﬁndings have been conﬁrmed by other study [13]. Based on our
study, even this highly experienced surgeon does not seem reliable
at determining which parathyroid gland are functioning, hence the
better results in the autotransplantation group.
A beneﬁt from inferior parathyroid glands autotransplantation
is that it might achieve comprehensive central neck compartment
dissection. Theoretically and technically, it is hard to ﬁnd a balance
between a complete CND and protection of parathyroid glands,
especially when inferior parathyroid and enlarged lymph nodes
mixed together. In order to avoid hypoparathyroidism, lymph node
“berry picking” were performed in practice, and this might have
been the most important causation of CNLN recurrence. It is
considered inappropriate and not recommended [16]. Based on our
study results, an interesting conception is if we can preserve su-
perior parathyroid glands in situ and routinely autotransplant
inferior parathyroid glands during CND. Some other studies re-
ported that parathyroid autotransplantation could reduce the risk
of permanent hypoparathyroidism [29e31]. The difference with
these previous studies is that the autotransplantation of inferior
parathyroid gland during CND would lead to a better CND and
reduce permanent hypoparathyroidism.
As a retrospective study, the bias of selectivity is unavoidable.
The results should be interpreted in the context of a major tertiary
referral center. Most of the patients referred to the hospital were
relatively late-staged. Previous studies reported that unilateral PTC
with a maximal diameter of >1 cm is associated with a high rate of
ipsilateral CNLN metastasis, and ipsilateral CNLN metastasis was a
potential independent predictor of concomitant contralateral par-
atracheal metastasis [32e34]. In order to obtain a better initial
treatment result, a bilateral CND should be considered. This would
not be common practice in western countries but common in
China. So our experience is helpful for developing countries with
much more advanced thyroid cancers.
In summary, we found that autotransplantation of inferior
parathyroid glands during CND for PTC provided lower incidence of
permanent hypoparathyroidism and CNLN recurrence for patients.
Among experienced surgeons, this surgery can be safely and
effectively performed. Obviously, it is much easier for surgeons to
perform parathyroid gland autotransplantation than to perform
parathyroid gland preservation in situ. Although further prospec-
tive study enrolling more patients with long-term follow-up is
needed, routine autotransplantation of inferior parathyroid glands
during CND might be considered based on this study.
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